Ashburton Jersey Ltd Sells 2,200 Shares of Monsanto Company (MON)
Ashburton Jersey Ltd lowered its position in Monsanto Company (NYSE:MON) by 10.2% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 19,442 shares of the basic materials company’s stock after selling 2,200 shares during the quarter. Monsanto makes up about 1.0% of Ashburton Jersey Ltd’s holdings, making the stock its 19th biggest holding. Ashburton Jersey Ltd’s holdings in Monsanto were worth $2,330,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently modified their holdings of MON. Scopus Asset Management L.P. lifted its stake in Monsanto by 66.7% in the first quarter. Scopus Asset Management L.P. now owns 125,000 shares of the basic materials company’s stock worth $14,150,000 after acquiring an additional 50,000 shares during the last quarter. BlueCrest Capital Management Ltd raised its holdings in Monsanto by 20.6% during the first quarter. BlueCrest Capital Management Ltd now owns 54,052 shares of the basic materials company’s stock worth $6,119,000 after purchasing an additional 9,241 shares in the last quarter. Investment Centers of America Inc. raised its holdings in Monsanto by 7.2% during the first quarter. Investment Centers of America Inc. now owns 4,619 shares of the basic materials company’s stock worth $530,000 after purchasing an additional 312 shares in the last quarter. Elliott Management Corp acquired a new stake in Monsanto during the first quarter worth approximately $50,081,000. Finally, Westover Capital Advisors LLC raised its holdings in Monsanto by 0.6% during the first quarter. Westover Capital Advisors LLC now owns 15,064 shares of the basic materials company’s stock worth $1,705,000 after purchasing an additional 92 shares in the last quarter. Institutional investors own 74.98% of the company’s stock.
Shares of Monsanto Company (MON) traded down $0.26 during trading on Friday, hitting $118.22. 1,847,100 shares of the stock were exchanged, compared to its average volume of 1,941,602. The firm has a market cap of $52,040.45, a PE ratio of 21.38, a price-to-earnings-growth ratio of 1.70 and a beta of 1.05. Monsanto Company has a fifty-two week low of $100.87 and a fifty-two week high of $122.79. The company has a quick ratio of 0.83, a current ratio of 1.35 and a debt-to-equity ratio of 1.12.
Monsanto (NYSE:MON) last announced its earnings results on Wednesday, October 4th. The basic materials company reported $0.20 EPS for the quarter, beating analysts’ consensus estimates of ($0.41) by $0.61. The business had revenue of $2.69 billion for the quarter, compared to analysts’ expectations of $2.51 billion. Monsanto had a net margin of 15.44% and a return on equity of 42.40%. The company’s quarterly revenue was up 4.8% on a year-over-year basis. During the same period in the previous year, the company posted $0.07 EPS. equities analysts expect that Monsanto Company will post 5.74 EPS for the current year.
A number of research firms have weighed in on MON. UBS AG cut shares of Monsanto from a “buy” rating to a “neutral” rating and set a $128.00 price objective on the stock. in a report on Friday, August 18th. Zacks Investment Research cut shares of Monsanto from a “buy” rating to a “hold” rating in a report on Wednesday, August 30th. Royal Bank Of Canada reissued a “hold” rating and set a $128.00 price objective on shares of Monsanto in a report on Wednesday, November 15th. Piper Jaffray Companies set a $128.00 price objective on shares of Monsanto and gave the stock a “buy” rating in a report on Friday, August 11th. Finally, Wells Fargo & Company raised their price objective on shares of Monsanto from $107.50 to $118.00 and gave the stock a “market perform” rating in a report on Tuesday, October 10th. Eleven investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus target price of $124.61.
In related news, VP Duraiswami Narain sold 2,860 shares of Monsanto stock in a transaction on Monday, September 25th. The shares were sold at an average price of $120.00, for a total value of $343,200.00. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, VP Nicole M. Ringenberg sold 7,890 shares of Monsanto stock in a transaction on Monday, October 16th. The shares were sold at an average price of $122.25, for a total transaction of $964,552.50. Following the completion of the transaction, the vice president now owns 38,600 shares in the company, valued at $4,718,850. The disclosure for this sale can be found here. Over the last quarter, insiders sold 49,236 shares of company stock worth $5,931,934. 0.79% of the stock is currently owned by insiders.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with Analyst Ratings Network's FREE daily email newsletter.